Novel ultra-long (48 mm) everolimus-eluting stent for diffusely disease coronary vessels.
CONCLUSIONS: The present real-world experience shows promising clinical results with the use of ultra-long stents in order to limit the need of stents overlaps in patients with diffuse coronary disease undergoing PCI.
PMID: 30895769 [PubMed - as supplied by publisher]
Source: Minerva Cardioangiologica - Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
More News: Angioplasty | Cardiogenic Shock | Cardiology | Coronary Angioplasty | Diabetes | Endocrinology | Heart | Percutaneous Coronary Intervention | Thrombosis